$52.03
8.64% yesterday
NYSE, Jul 14, 10:19 pm CET
ISIN
US4330001060
Symbol
HIMS

Hims & Hers Health Inc. Stock price

$52.03
-7.75 12.96% 1M
+25.82 98.51% 6M
+27.85 115.18% YTD
+29.19 127.80% 1Y
+46.60 858.20% 3Y
+41.65 401.01% 5Y
+42.23 430.92% 10Y
+42.23 430.92% 20Y
NYSE, Closing price Mon, Jul 14 2025
+4.14 8.64%
ISIN
US4330001060
Symbol
HIMS
Industry

Key metrics

Basic
Market capitalization
$10.7b
Enterprise Value
$10.4b
Net debt
positive
Cash
$322.7m
Shares outstanding
223.6m
Valuation (TTM | estimate)
P/E
72.6 | 70.3
P/S
6.0 | 4.5
EV/Sales
5.8 | 4.3
EV/FCF
44.0
P/B
19.5
Financial Health
Equity Ratio
67.4%
Return on Equity
26.4%
ROCE
18.9%
ROIC
47.0%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$1.8b | $2.4b
EBITDA
$137.9m | $330.4m
EBIT
$115.6m | $193.7m
Net Income
$164.4m | $152.3m
Free Cash Flow
$236.5m
Growth (TTM | estimate)
Revenue
86.0% | 62.3%
EBITDA
2,697.8% | 288.3%
EBIT
2,214.4% | 184.8%
Net Income
7,095.7% | 20.9%
Free Cash Flow
355.7%
Margin (TTM | estimate)
Gross
77.0%
EBITDA
7.7% | 13.8%
EBIT
6.5%
Net
9.2% | 6.4%
Free Cash Flow
13.3%
More
EPS
$0.7
FCF per Share
$1.1
Short interest
34.2%
Employees
1k
Rev per Employee
$1.4m
Show more

Is Hims & Hers Health Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Hims & Hers Health Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Hims & Hers Health Inc. forecast:

9x Buy
45%
9x Hold
45%
2x Sell
10%

Analyst Opinions

20 Analysts have issued a Hims & Hers Health Inc. forecast:

Buy
45%
Hold
45%
Sell
10%

Financial data from Hims & Hers Health Inc.

Mar '25
+/-
%
Net Profit 164 164
7,096% 7,096%
9%
Depreciation and Amortization 22 22
115% 115%
1%
Stock Compensation 98 98
38% 38%
6%
Operating Cash Flow 334 334
272% 272%
19%
Investments 98 98
158% 158%
5%
Dividend Paid - -
-
-
Free Cash Flow 237 237
356% 356%
13%

In millions USD.

Don't miss a Thing! We will send you all news about Hims & Hers Health Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hims & Hers Health Inc. Stock News

Neutral
Business Wire
about 7 hours ago
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter 2025 financial results after the market closes on Monday, August 4, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing...
Neutral
PRNewsWire
about 9 hours ago
NEW YORK , July 14, 2025 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the "Class Period"), of the important August 25, 2025 lead plaintiff deadline. So what: If you purchased Hims common stock during the Class Period you may be e...
Neutral
GlobeNewsWire
4 days ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options
More Hims & Hers Health Inc. News

Company Profile

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Head office United States
CEO Andrew Dudum
Employees 1,046
Founded 2017
Website www.forhims.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today